Filing Details

Accession Number:
0001415889-14-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-08 16:30:11
Reporting Period:
2014-01-07
Filing Date:
2014-01-08
Accepted Time:
2014-01-08 16:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1402785 Fluoropharma Medical Inc. FPMI In Vitro & In Vivo Diagnostic Substances (2835) 208325616
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535289 M. Johan Spoor 8 Hillside Avenue, Suite 207
Montclair NJ 07042
Ceo, President, Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-07 10,000 $0.50 200,398 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrants Acquisiton 2014-01-07 10,000 $0.00 10,000 $0.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2014-01-07 2019-01-07 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Series B Convertible Preferred Stock $0.80 2013-09-25 18,750 18,750 Direct
Common Stock Common Stock Purchase Warrants $0.83 2013-09-25 2018-09-25 24,956 24,956 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
18,750 18,750 Direct
2018-09-25 24,956 24,956 Direct
Footnotes
  1. The Series B Convertible Preferred is perpetual and has no expiration date.